MICHELE NEUDECKER: Open Payments
NPI 1851381206 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 42 payments from 15 companies in 2025. Trend: 2023 $752 · 2024 $1,312 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $312 |
| Lilly USA, LLC | 4 | $138 |
| Novo Nordisk Inc | 6 | $97 |
| PFIZER INC. | 3 | $68 |
| Exact Sciences Corporation | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Amgen Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: QULIPTA, UBRELVY, Wegovy, Cologuard Collection Kit, CAPLYTA, AIRSUPRA, JARDIANCE, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
